VEG113971: An Open-Label Study of the Effects of Ketoconazole or Esomeprazole on Pazopanib PK
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how dosing with ketoconazole (Nizoral) or
esomeprazole (Nexium) affects the pharmacokinetics of oral pazopanib. The study will also
test for safety of pazopanib when administered with ketoconazole or esomeprazole.